← Back to Search

Conversation Therapy for Aphasia

N/A
Recruiting
Led By Gayle DeDe, PhD
Research Sponsored by Boston University Charles River Campus
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Clinical diagnosis of aphasia
Participants with severe aphasia (Cycle 2)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and up to 12 weeks after baseline
Awards & highlights

Study Summary

This trial will test the efficacy of group conversation treatment for people with aphasia, looking at factors such as group size and composition, and severity of aphasia.

Who is the study for?
This trial is for English-speaking adults with aphasia, a language disorder typically caused by stroke. They must be at least 6 months post-stroke and have enough understanding to join in conversations. The study includes all severity levels of aphasia but excludes those with other neurological diseases, developmental disabilities, or serious illnesses like cancer.Check my eligibility
What is being tested?
The study tests group conversation treatment's effectiveness on communication skills in people with aphasia. It examines how different group sizes (2 vs. 6-8 people) and compositions (similar vs. different types of aphasia), as well as the severity of aphasia, impact the treatment outcome.See study design
What are the potential side effects?
Since this is a non-medical intervention focusing on speech therapy through conversation practice, there are no direct medical side effects expected from participating in this trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with difficulty in speaking or understanding language.
Select...
I have severe difficulty speaking or understanding speech.
Select...
I am a native English speaker.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and up to 12 weeks after baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and up to 12 weeks after baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Scores on Aphasia Communication Outcome Measure from Pre- to Post- Treatment
Change in Scores on Aphasia Communication Outcome Measure from Pre-Treatment to One month Post-Treatment
Secondary outcome measures
Aphasia Tests
Aphasia Tests

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Experimental: Group compositionExperimental Treatment1 Intervention
Outcomes will be measured for individuals who participate in homogeneous compared to heterogeneous groups (6-8 people with aphasia), based on aphasia severity (severe vs. mild-moderate aphasia).
Group II: Experimental: Group Size x Aphasia SeverityExperimental Treatment1 Intervention
Outcomes will be measured for individuals who participate in large group (6-8 group members) compared to dyads (2 group members), and whether this relationship differs as a function of aphasia severity (severe vs. mild-moderate aphasia).
Group III: Treatment efficacy: Delayed Control GroupActive Control1 Intervention
Treatment cycle 1 only.

Find a Location

Who is running the clinical trial?

Boston University Charles River CampusLead Sponsor
114 Previous Clinical Trials
12,122 Total Patients Enrolled
3 Trials studying Aphasia
382 Patients Enrolled for Aphasia
Temple UniversityOTHER
297 Previous Clinical Trials
82,805 Total Patients Enrolled
3 Trials studying Aphasia
384 Patients Enrolled for Aphasia
Adler Aphasia CenterUNKNOWN

Media Library

Conversation Treatment for Aphasia Clinical Trial Eligibility Overview. Trial Name: NCT05113160 — N/A
Aphasia Research Study Groups: Treatment efficacy: Delayed Control Group, Experimental: Group Size x Aphasia Severity, Experimental: Group composition
Aphasia Clinical Trial 2023: Conversation Treatment for Aphasia Highlights & Side Effects. Trial Name: NCT05113160 — N/A
Conversation Treatment for Aphasia 2023 Treatment Timeline for Medical Study. Trial Name: NCT05113160 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is eligibility for this trial limited to participants under the age of 35?

"For this medical trial, only individuals aged 18 and up to 85 years old may participate."

Answered by AI

How many participants are included in this clinical investigation?

"In pursuit of a successful clinical trial, this study requires 168 qualified participants. For convenience, there are multiple locations that can be accessed including Temple University in Philadelphia and Adler Aphasia Center located in Maywood."

Answered by AI

Do I satisfy the criteria for participating in this research project?

"This clinical trial seeks to recruit 168 individuals aged 18-85 with aphasia. To be eligible, patients must have experienced an ischemic stroke on the language dominant hemisphere at least 6 months prior and demonstrate adequate auditory comprehension abilities through standardized tests. Additionally, participants cannot possess any other neurological disease apart from their stroke nor can they partake in external speech therapy during this study. The experimental group will comprise of all types and severities of aphasia and only native English speakers are sought after."

Answered by AI

Is this medical trial currently seeking participants?

"Affirmative. According to clinicaltrials.gov, this medical examination began recruiting on April 15th 2022 and has since been updated on February 15th of the same year. 168 volunteers are needed from 3 distinct trial sites."

Answered by AI

Who else is applying?

What site did they apply to?
Boston University - Charles River Campus
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Conversation Group Treatment for Aphasia: Does it Work?
2022. "Conversation Group Treatment for Aphasia: Does it Work?". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05113160.
All > Aphasia
~76 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top